Apitoria Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is PALIPERIDONE PALMITATE, with a corresponding US DMF Number 38744.
Remarkably, this DMF maintains an Active status since its submission on September 06, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 25, 2023, and payment made on August 22, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II